Skip to main content
. 2020 Jul 1;133(15):1856–1867. doi: 10.1097/CM9.0000000000000921

Figure 1.

Figure 1

Common signaling pathway with miRNAs involved in the different malignant phenotypes of gastric cancer. Akt: Protein kinase B; ALEX1: Arm protein lost in epithelial cancers on chromosome X 1; Bmi-1: B-lymphoma moloney murine leukemia virus insertion region-1; CypB: Cyclophilin B; EGFR: Epidermal growth factor receptor; ERK: Extracellular signal-regulated kinase; HER-2: Human epidermal growth factor receptor 2; IKK-β: IκB kinase-β; JAK: Janus kinase; MAPK: Mitogen-activated protein kinase; MEG2: Protein-tyrosine phosphatase megakaryocyte 2; MEK: Mitogen-activated protein kinase; MST1: Mammalian sterile 20-like 1; NF-κB: Nuclear factor-κB; POU2F2: POU class 2 homeobox 2; PTEN: Phosphatase and tensin homolog; RASSF8: Ras-association domain family 8; SLC34A2: Solute carrier 34 A2; SLIT2/ROBO1: Slit guidance ligand 2/a ligand of the roundabout 1; Smad4: Drosophila protein, mothers against decapentaplegic homolog 4; STAT3: Signal transducer and activator of transcription 3; SUFU: Suppressor of fused homolog; TGF-β: Transforming growth factor-β; YAP1: YES-associated protein 1; YES1: YES proto-oncogene 1.